Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Sep;54(3):756-758.
doi: 10.1007/s12029-022-00884-2. Epub 2022 Nov 18.

A Seed in the Soil - Isolated Esophageal Cancer Recurrence in the Brain After Trimodality Treatment is more Common than Expected but Associated with Better Outcomes

Dana Ferrari-Light  1 , Robert E Merritt  1 , Peter J Kneuertz  2
Affiliations
Editorial

A Seed in the Soil - Isolated Esophageal Cancer Recurrence in the Brain After Trimodality Treatment is more Common than Expected but Associated with Better Outcomes

Dana Ferrari-Light et al. J Gastrointest Cancer. 2023 Sep.
No abstract available

Keywords: Brain metastases; Esophageal cancer; Esophagectomy; Oligometastatic; Recurrence; Trimodality.

PubMed Disclaimer

Comment on

References

    1. Smith RS, Foster NR, Jatoi A, Thome SD, Miller RC. Incidence of brain metastasis as first event in patients with esophageal carcinoma: a report from three prospective alliance clinical trials. J Gastrointest Cancer. 2022. Epub 2022/10/18. https://doi.org/10.1007/s12029-022-00871-7 . PubMed PMID: 36251211.
    1. Stuart SK, Kuypers TJL, Martijnse IS, Heisterkamp J, Matthijsen RA. Patients with isolated brain metastases from esophageal carcinoma after minimally invasive esophagectomy may not have a dismal prognosis. J Gastrointest Cancer. 2022. Epub 2022/10/04. https://doi.org/10.1007/s12029-022-00870-8 . PubMed PMID: 36192598.
    1. Cleary JM, Mamon HJ, Szymonifka J, Bueno R, Choi N, Donahue DM, Fidias PM, Gaissert HA, Jaklitsch MT, Kulke MH, Lynch TP, Mentzer SJ, Meyerhardt JA, Swanson RS, Wain J, Fuchs CS, Enzinger PC. Neoadjuvant irinotecan, cisplatin, and concurrent radiation therapy with celecoxib for patients with locally advanced esophageal cancer. BMC Cancer. 2016;16:468. Epub 2016/07/15. https://doi.org/10.1186/s12885-016-2485-9 . PubMed PMID: 27412386; PMCID: PMC4944495.
    1. Yoon HH, Lewis MA, Foster NR, Sukov WR, Khan M, Sattler CA, Wiktor AE, Wu TT, Jenkins RB, Sinicrope FA. Central nervous system relapse in patients with untreated HER2-positive esophageal or gastroesophageal junction adenocarcinoma. Int J Cancer. 2016;139(7):1626–31. Epub 2016/05/21. https://doi.org/10.1002/ijc.30200 . PubMed PMID: 27198655; PMCID: PMC6631306.
    1. Wadhwa R, Taketa T, Correa AM, Sudo K, Campagna MC, Blum MA, Komaki R, Skinner H, Lee JH, Bhutani MS, Weston B, Maru DM, Rice DC, Swisher S, Hofstetter WL, Ajani JA. Incidence of brain metastases after trimodality therapy in patients with esophageal or gastroesophageal cancer: implications for screening and surveillance. Oncology. 2013;85(4):204–7. Epub 2013/09/21. https://doi.org/10.1159/000354736 . PubMed PMID: 24051869.

LinkOut - more resources